Literature DB >> 36262536

Insulin-like growth factor 1 and dehydroepiandrosterone levels in alcoholic liver cirrhosis.

Werner Dammermann1, Benedikt Seckinger1, David Füller1, Stefan Lüth1, Florian Hentschel1.   

Abstract

Anabolic hormones in liver cirrhosis are suspected to be lower than in healthy individuals. In a group of 22 cirrhosis patients, we found lower levels of insulin-like growth factor 1, but-surprisingly-higher levels of dehydroepiandrosterone.
© 2022 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  anabolism; dehydroepiandrosterone; insulin‐like growth factor 1; liver cirrhosis; sarcopenia; steroid hormones

Year:  2022        PMID： 36262536      PMCID： PMC9575319          DOI： 10.1002/jgh3.12809

Source DB:  PubMed          Journal:  JGH Open        ISSN： 2397-9070


  15 in total

1.  SARC-F: a simple questionnaire to rapidly diagnose sarcopenia.

Authors:  Theodore K Malmstrom; John E Morley
Journal:  J Am Med Dir Assoc       Date:  2013-06-25       Impact factor: 4.669

2.  Prognostic significance of insulin-like growth factor-I serum levels in acute decompensation of cirrhosis.

Authors:  Bruno da Silveira Colombo; Marcelo Fernando Ronsoni; Pedro Eduardo Soares E Silva; Leonardo Fayad; Letícia Muraro Wildner; Maria Luiza Bazzo; Esther Buzaglo Dantas-Correa; Janaína Luz Narciso-Schiavon; Leonardo Lucca Schiavon
Journal:  Biomarkers       Date:  2016-11-07       Impact factor: 2.658

Review 3.  The Role of Dehydroepiandrosterone (DHEA) in Skeletal Muscle.

Authors:  Koji Sato; Motoyuki Iemitsu
Journal:  Vitam Horm       Date:  2018-05-03       Impact factor: 3.421

4.  Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis.

Authors:  Samir Ahboucha; Gilles Pomier-Layrargues; Catherine Vincent; Ziad Hassoun; Raja Tamaz; Glen Baker; Roger F Butterworth
Journal:  Neurochem Int       Date:  2007-06-19       Impact factor: 3.921

5.  Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease score.

Authors:  Marie Sinclair; Paul J Gow; Mathis Grossmann; Adam Shannon; Rudolf Hoermann; Peter W Angus
Journal:  Liver Transpl       Date:  2016-11       Impact factor: 5.799

6.  Association between Low Testosterone Levels and Sarcopenia in Cirrhosis: A Cross-sectional Study.

Authors:  Carlos Moctezuma-Velázquez; Gavin Low; Marina Mourtzakis; Mang Ma; Kelly W Burak; Puneeta Tandon; Aldo J Montano-Loza
Journal:  Ann Hepatol       Date:  2018 July - August ,       Impact factor: 2.400

7.  Handgrip strength as a valid practical tool to screen early-onset sarcopenia in acute care wards: a first evaluation.

Authors:  Marie Blanquet; Guillaume Ducher; Anaïs Sauvage; Sylvain Dadet; Vincent Guiyedi; Nicolas Farigon; Candy Guiguet-Auclair; Pauline Berland; Jérôme Bohatier; Yves Boirie; Laurent Gerbaud
Journal:  Eur J Clin Nutr       Date:  2021-04-13       Impact factor: 4.016

8.  Developing sarcopenia criteria and cutoffs for an older Caucasian cohort - a strictly biometrical approach.

Authors:  Wolfgang Kemmler; Simon von Stengel; Matthias Kohl
Journal:  Clin Interv Aging       Date:  2018-08-02       Impact factor: 4.458

9.  Dehydroepiandrosterone modulates oxidative DNA damage in pancreatic cancer: A case-control study.

Authors:  Hamid Reza Fazli; Ashraf Mohamadkhani; Hamed Reza Godarzi; Akram Pourshams; Mojtaba Jafari Nia
Journal:  JGH Open       Date:  2021-06-26

10.  Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis.

Authors:  Chisato Saeki; Tomoya Kanai; Masanori Nakano; Tsunekazu Oikawa; Yuichi Torisu; Masayuki Saruta; Akihito Tsubota
Journal:  JGH Open       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.